Table 3 Susceptibility of S. aureus and P. aeruginosa to antimicrobial agents by disc diffusion
Antibiotics | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
β-lactams | aminoglycosides | macrolides lincosamides | fluoroquinolones | tetracyclines | others | |||||||||||
S. aureus (number) | PEN | FOX | GEN | AMK | ERY | CLI | OFX | LVX | CIP | TGC | FAD | RIF | LZD | VNC | ||
MSSA (5) | R | S | S | S | S/I | S/I | S | S | S | S/R | S/R | S | S | S | ||
MRSA (5) | R | R | S/R | S/R | S/I/R | S/R | S/R | S/R | S/R | S | S/R | S/I/R | S | S | ||
β-lactams | aminoglycosides | quinolones | others | |||||||||||||
P. aeruginosa (number) | PIL | PTZ | TIC | TCC | CZD | FEP | ATM | IPM | MEM | AMK | GEN | TMN | CIP | NAL | RIF | FOF |
AS (6) | S/R | S/R | S/R | S/R | S | S | I | S/I | S | S/I | S/R | S | S/I/R | R | R | S/R |
MDRPA (5) | R | R | R | R | R | R | I/R | I/R | I/R | S/I/R | S/R | S/R | R | R | R | S/R |